The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team.
News | FDA
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy Earns FDA Approval for Tricuspid Valve

February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is ...

Home February 02, 2024
Home
A new paper in JAMA describes how, despite widespread enthusiasm about AI’s potential and the current use of AI-powered tools, no federal regulations require that AI-powered tools be evaluated for potential harm or benefit to patients
News | Artificial Intelligence
Paper Calls for Patient-first Regulation of AI in Healthcare

February 1, 2024 — Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the ...

Home February 01, 2024
Home
In addressing efficacy, harm, and logistics, the study passes all three of the criteria suggested by the American Heart Association guiding the implementation of polygenic risk scores (PRSs) in cardiovascular care
News | Cardiovascular Clinical Studies
Genomics plc Publishes Clinical Trial Results Demonstrating Successful Integration and Clinical Utility of Integrated Risk Scores Combining Polygenic and Clinical Risk of Cardiovascular Disease in NHS Primary Care

February 1, 2024 — Genomics plc (Genomics), a healthcare company aiming to transform health through the power of ...

Home February 01, 2024
Home
As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, ITN has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market.
Feature | Cardiovascular Education | Christine Book
American Heart Month Puts Spotlight on Cardiovascular Disease and Stroke Statistics

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

Home February 01, 2024
Home
Here is a look at the most-read content during the month of January on dicardiology.com
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in January

It is a new year with lots of new content! Here is a look at the most-read content during the month of January on ...

Home February 01, 2024
Home
Latest innovation has the potential to reduce anesthesia during minimally invasive procedures
News | Transesophageal Echo (TEE)
New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

January 31, 2024 — Royal Philips, a global leader in health technology, announced that its latest TEE transducer ...

Home January 31, 2024
Home
Outlines methods for interventional cardiologists to identify types of calcified coronary lesions and presents an algorithm to guide the use of calcium modification strategies
News | Angiography
SCAI Publishes Expert Consensus Statement on Management of Calcified Coronary Lesions Requiring Intervention

January 31, 2024 — Coronary artery calcification is increasing in prevalence, leading to greater risks both during ...

Home January 31, 2024
Home
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts
News | FDA
W. L. Gore Receives FDA Approval for Lower Profile Gore Viabahn VBX Balloon Expandable Endoprosthesis

January 31, 2024 — As part of efforts to continuously improve medical solutions for patients with complex vascular ...

Home January 31, 2024
Home
The U.S. Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System.
News | FDA
Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

January 31, 2024 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home January 31, 2024
Home
Study Reveals Nuances in Pediatric Cardiac Surgery Quality Metrics
News | STS
New Research Finds Volume Alone Does Not Predict Quality Outcomes in Pediatric Cardiac Surgery

January 30, 2024 — A study of pediatric heart surgery centers across the United States has demonstrated that, when it ...

Home January 30, 2024
Home
Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessment
News | Heart Failure
Johns Hopkins Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease

January 30, 2024 — Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single ...

Home January 30, 2024
Home
Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessment
News | Sudden Cardiac Arrest
Emergency Cardiovascular Care Impact Goal Outlines 3 Target Needs

January 30, 2024 — Only 10% of people who experience a cardiac arrest survive.[1] In new challenge goals outlined in the ...

Home January 30, 2024
Home
A new study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, examines the ongoing controversy surrounding the choice between multi-arterial grafting (MAG) and single arterial grafting (SAG) in coronary artery bypass grafting (CABG) for multivessel coronary revascularization
News | STS
New Research Highlights Superior Long-Term Survival with Multi-Arterial Coronary Artery Bypass Grafting Over Single Arterial Grafting

January 29, 2024 — A new study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas ...

Home January 29, 2024
Home
Researchers uncover critical factors for improved patient safety in lung cancer resection– An analysis of the STS general thoracic surgery database
News | Pulmonary Embolism
Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer

January 29, 2024 — In patients who undergo pulmonary resection for lung cancer, a major potential postoperative ...

Home January 29, 2024
Home
Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis, many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates
News | Cardiovascular Surgery
Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under ...

Home January 29, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now